Alexandre Colas, Ph.D.

Alexandre Colas' Research Focus

Heart Disease, Cardiovascular Diseases, Cardiomyopathies
Development and Differentiation, Embryonic/Pluripotent Stem Cells, Cardiovascular Biology, Regenerative Biology, Transcription Factors, RNA-Based Gene Regulation, Embryogenesis, Cell Biology

Our laboratory focuses on the identification and reconstruction of novel regulatory pathways controlling the determination and the acquisition of cardiovascular cell fates in humans. To that end, our team has developed a unique set of cell-based assays suitable for high-throughput functional screening, which enables the implementation of unbiased and systematic experimental approaches with unprecedented exploratory power. Our goal is to leverage generated knowledge to produce better cardiomyocytes to model cardiac diseases in-a-dish as well as to devise innovative cardiac regenerative strategies. In parallel, our lab is also dedicated to identify and develop new drugs promoting cardiac regeneration and/or helping preserving heart function after injury.

Alexandre Colas' Bio

Dr. Colas earned his Ph.D. from the Universite Pierre et Marie Curie, Paris, France.
 

Funding Awards and Collaborative Grants

2011-2013: American Heart Association Post-Doctoral Fellowship
2011: Best Talk Award (Development & Aging Post-Doctoral Retreat, SBP)
2010-2011: California Institute for Regenerative Medicine Post-Doctoral Fellowship
2006-2007: French Myopathy Association Ph.D. Fellowship
2003-2006: Ministry of French Research Ph.D. Fellowship
2000-2001: Erasmus Undergraduate Fellowship


general accessory

Publications

Retinoic Acid Activity in Undifferentiated Neural Progenitors Is Sufficient to Fulfill Its Role in Restricting Fgf8 Expression for Somitogenesis.

Cunningham TJ, Brade T, Sandell LL, Lewandoski M, Trainor PA, Colas A, Mercola M, Duester G

PLoS One 2015 ;10(9):e0137894

Induced pluripotent stem cells in cardiovascular drug discovery.

Mercola M, Colas A, Willems E

Circ Res 2013 Feb 1 ;112(3):534-48

Serum-free generation of multipotent mesoderm (Kdr+) progenitor cells in mouse embryonic stem cells for functional genomics screening.

McKeithan WL, Colas AR, Bushway PJ, Ray S, Mercola M

Curr Protoc Stem Cell Biol 2012 Nov ;Chapter 1:Unit 1F.13

Show All Select Publications

The nutrient sensor CRTC & Sarcalumenin / Thinman represent a new pathway in cardiac hypertrophy.

Dondi C, Vogler G, Gupta A, Walls SM, Kervadec A, Romero MR, Diop SB, Goode J, Thomas JB, Colas AR, Bodmer R, Montminy M, Ocorr K

bioRxiv 2023 Oct 2 ;

Mitochondrial MICOS complex genes, implicated in hypoplastic left heart syndrome, maintain cardiac contractility and actomyosin integrity.

Birker K, Ge S, Kirkland NJ, Theis JL, Marchant J, Fogarty ZC, Missinato MA, Kalvakuri S, Grossfeld P, Engler AJ, Ocorr K, Nelson TJ, Colas AR, Olson TM, Vogler G, Bodmer R

Elife 2023 Jul 5 ;12

Multiplatform modeling of atrial fibrillation identifies phospholamban as a central regulator of cardiac rhythm.

Kervadec A, Kezos J, Ni H, Yu M, Marchant J, Spiering S, Kannan S, Kwon C, Andersen P, Bodmer R, Grandi E, Ocorr K, Colas AR

Dis Model Mech 2023 Jul 1 ;16(7)

Trajectory reconstruction identifies dysregulation of perinatal maturation programs in pluripotent stem cell-derived cardiomyocytes.

Kannan S, Miyamoto M, Zhu R, Lynott M, Guo J, Chen EZ, Colas AR, Lin BL, Kwon C

Cell Rep 2023 Apr 25 ;42(4):112330

Conserved transcription factors promote cell fate stability and restrict reprogramming potential in differentiated cells.

Missinato MA, Murphy S, Lynott M, Yu MS, Kervadec A, Chang YL, Kannan S, Loreti M, Lee C, Amatya P, Tanaka H, Huang CT, Puri PL, Kwon C, Adams PD, Qian L, Sacco A, Andersen P, Colas AR

Nat Commun 2023 Mar 27 ;14(1):1709

Genetic architecture of natural variation of cardiac performance from flies to humans.

Saha S, Spinelli L, Castro Mondragon JA, Kervadec A, Lynott M, Kremmer L, Roder L, Krifa S, Torres M, Brun C, Vogler G, Bodmer R, Colas AR, Ocorr K, Perrin L

Elife 2022 Nov 16 ;11

Show All Publications